London, UK – November 12, 2025 — Oriflame announced the results of new research demonstrating the effects of its patented Oripeptide-3 technology on key hallmarks of skin ageing. The study found this peptide complex can positively influence cellular senescence, genomic instability, proteostasis, mitochondrial dysfunction and impaired autophagy—five of the major ageing mechanisms—painting a new era for skin-longevity science.
Science Significance
This research advances the field of skin-longevity science by linking peptide technology to the underlying biology of ageing rather than simply surface appearance. The study identified that Oripeptide-3 substantially modulates five principal ageing mechanisms—cellular senescence, genomic instability, loss of proteostasis, mitochondrial dysfunction and impaired autophagy. By targeting these mechanisms, the peptide complex goes beyond traditional cosmetic effects to a biotechnological intervention in skin health. As such, it aligns cosmetic science with broader therapeutic approaches to ageing, and supports the evolution of cosmeceuticals into medically-adjacent biotech innovations.
Regulatory Significance
Though positioned as a cosmetic product, the peptide technology described may draw regulatory attention because it intersects with claims of skin-longevity, cellular repair and ageing mechanisms. Regulators centred on consumer-health representation may monitor such claims under cosmetic and possibly quasi-therapeutic frameworks, especially in jurisdictions with stricter oversight on anti-ageing products. Oriflame’s adherence to safety, bio-compatibility testing, and transparent mechanism-of-action disclosures positions the company to navigate evolving cosmetic-health regulatory landscapes across Europe, Asia and beyond.
Business Significance
Advertisement
From a business perspective, Oriflame’s announcement reinforces its differentiation in a highly competitive skincare market by offering a scientific, mechanism-driven ingredient technology. The global anti-ageing skincare market is projected to reach tens of billions of dollars, and incorporation of biotech-backed peptides offers premium positioning. By leveraging Oripeptide-3 in its NovAge+ line, Oriflame not only strengthens its own brand but also sets the stage for ingredient licensing, collaboration with dermatology research partners and deeper penetration of the cosmeceutical niche. This research outcome may also drive consumer trust and premium pricing, reinforcing long-term growth.
Patients’ Significance
For consumers—considered “skin-health patients” in the wider wellbeing context—the new research means access to skincare that is not just aesthetic but biologically meaningful. By addressing the underlying mechanisms of skin ageing, Oripeptide-3 supports improved skin resilience, longer-lasting youthfulness and potentially reduced need for more invasive dermatological interventions. Users may experience firmer, more elastic skin, fewer wrinkles and improved skin health overall, supporting both aesthetic and psychological wellbeing.
Policy Significance
The research ties into broader policy issues around ageing populations, preventive skin health and consumer-protection regulation. Governments and health authorities are increasingly recognising skin health as a component of overall ageing-wellness strategies. Ingredients backed by scientific data like Oripeptide-3 may prompt regulatory bodies to update guidance on cosmeceuticals, ingredient substantiation and consumer claims. Oriflame’s research thus aligns with policy trends promoting transparency in skincare science and the integration of biotech into everyday health-care products.
Oriflame’s new findings on Oripeptide-3 mark a pivotal moment in the evolution of skincare—from surface-level beautification to biologically informed skin-longevity science. By targeting core ageing mechanisms, the company sets a new benchmark for cosmeceutical innovation, bridging cosmetic appeal with biotech efficacy. As Oripeptide-3 enters consumer products, it redefines how we think about skin health, ageing and prevention—offering a scientific path to lasting resilience and renewed confidence in skin wellness.
Source: Oriflame press release
